Intramuscular botulinum toxin prior to comprehensive rehabilitation has no added value for improving motor impairments, gait kinematics and goal attainment in walking children with spastic cerebral palsy

• Main Authors: Fabienne Schasfoort (Author), Robert Pangalila (Author), Emiel M. Sneekes (Author), Coriene Catsman (Author), Jules Becher (Author), Herwin Horemans (Author), Henk J. Stam (Author), Annet J. Dallmeijer (Author), Johannes B.J Bussmann (Author)
• 格式: 圖書
• 出版: Medical Journals Sweden, 2018-07-01T00:00:00Z.
• 主題: article
• 在線閱讀: Connect to this object online.

Objective: Botulinum toxin (BoNT-A) is widely used in combined treatment for spastic cerebral palsy, but its added value preceding comprehensive rehabilitation for motor impairments, gait, and goal attainment has not been studied. Design: A comparative multi-centre trial, in which two groups underwe...